Mostrar el registro sencillo del ítem

Tratamiento farmacológico y no farmacológico de la enfermedad pulmonar obstructiva crónica

dc.contributor.authorMolina-Franky, Jessicaspa
dc.contributor.authorRoa Cubaque, Marcela Américaspa
dc.contributor.authorCorredor Gamba, Sandra Patriciaspa
dc.contributor.authorPolanía Robayo, Alba Yaniraspa
dc.contributor.authorRojas Laverde, Maria del Pilarspa
dc.date.accessioned2018-09-03 00:00:00
dc.date.accessioned2022-03-08T16:18:43Z
dc.date.available2018-09-03 00:00:00
dc.date.available2022-03-08T16:18:43Z
dc.date.issued2018-09-03
dc.identifier.issn2389-7325
dc.identifier.urihttps://repositorio.uniboyaca.edu.co/handle/uniboyaca/361
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad de Boyacáspa
dc.rightsRevista Investigación en Salud Universidad de Boyacá - 2018spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0spa
dc.sourcehttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/view/345spa
dc.subjectmedicina internaspa
dc.subjectneumologíaspa
dc.subjectenfermedad pulmonar obstructiva crónicaspa
dc.subjecthábito de fumarspa
dc.subjectbroncodilatadoresspa
dc.subjectinternal medicineeng
dc.subjectpulmonary medicineeng
dc.subjectchronic obstructive pulmonary diseaseeng
dc.subjectsmokingeng
dc.subjectbronchodilator agentseng
dc.subjectmedicina internaeng
dc.subjectpneumologiaeng
dc.subjectdoença pulmonar obstrutiva crônicaeng
dc.subjecthábito de fumareng
dc.subjectbroncodilatadoreseng
dc.titleTratamiento farmacológico y no farmacológico de la enfermedad pulmonar obstructiva crónicaspa
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.identifier.doi10.24267/23897325.345
dc.identifier.eissn2539-2018
dc.identifier.urlhttps://doi.org/10.24267/23897325.345
dc.relation.bitstreamhttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/download/345/448
dc.relation.citationeditionNúm. 2 , Año 2018 : Revista Investigación en Salud Universidad de Boyacáspa
dc.relation.citationendpage322
dc.relation.citationissue2spa
dc.relation.citationstartpage295
dc.relation.citationvolume5spa
dc.relation.ispartofjournalRevista Investigación en Salud Universidad de Boyacáspa
dc.relation.referencesThorpe O, Kumar S, Johnston K. Barriers to and enablers of physical activity in patients with COPD following a hospital admission: A qualitative study. Int J COPD. 2014;9:115-28. https://doi.org/10.2147/COPD.S54457spa
dc.relation.referencesRamon MA, Gimeno-Santos E, Ferrer J, Balcells E, Rodríguez E, De Batlle J, et al. Hospital admissions and exercise capacity decline in patients with COPD. Eur Respir J. 2014;43(4):1018-27. https://doi.org/10.1183/09031936.00088313spa
dc.relation.referencesRaluy-Callado M, Lambrelli D, MacLachlan S, Khalid JM. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Int J Chron Obstruct Pulmon Dis. 2015;10:925-37. https://doi.org/10.2147/COPD.S82064spa
dc.relation.referencesFarias CC, Resqueti V, Dias FAL, Borghi-Silva A, Arena R, Fregonezi GA de F. Costs and benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: a randomized controlled trial. Braz J Phys Ther. 2014;18(2):165-73. http://dx.doi.org/10.1590/S1413-35552012005000151spa
dc.relation.referencesOsthoffa M, Jenkins C, Leuppi JD. Chronic obstructive pulmonary disease-A treatable disease. Swiss Med Wkly. 2013;143:1-8. https://doi.org/10.4414/smw.2013.13777spa
dc.relation.referencesHealth O, Assessment T. Chronic obstructive pulmonary disease (COPD) evidentiary framework. Ont Health Technol Assess Ser. 2012;12(2):1-97.spa
dc.relation.referencesGlobal Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Revised 2012). 2012. 90 p.spa
dc.relation.referencesKoul P a, Khan UH, Asad R, Yousuf R, Broor S, Lal RB, et al. Contribution of influenza to acute exacerbations of chronic obstructive pulmonary disease in Kashmir, India, 2010-2012. Influenza Respir Viruses. 2015;9(1):40-42. https://doi.org/10.1111/irv.12291spa
dc.relation.referencesLópez-Giraldo a, Rodriguez-Roisin R, Agustí A. Enfermedad pulmonar obstructiva crónica. Actualización 2014. Med Balear. 2014;29(1):43-48. https://doi.org/10.3306/MEDICINABALEAR.29.01.43spa
dc.relation.referencesBello S, Chamorro H, Barrientos A. Tratamiento del tabaquismo en pacientes con enfermedad pulmonar obstructiva crónica. Rev Chil Enf Respir. 2013;29:24-30. http://dx.doi.org/10.4067/S0717-73482013000100004.spa
dc.relation.referencesLondoño D. Guía de práctica clínica basada en la evidencia para la prevención, diagnóstico, tratamiento y seguimiento de la enfermedad pulmonar obstructiva crónica en población adulta. Ministerio de Salud y Protección Social-Colciencias. Minist Protección Soc Colomb. 2014;(28).spa
dc.relation.referencesSecretaría de salud de Boyacá. ASIS BOYACÁ. Tunja; 2011.spa
dc.relation.referencesPolatli M, Bilgin C, Saylan B, Baslilar S, Toprak E, Ergen H, et al. A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study. Tuberk Toraks. 2012;60(1):1-12. https://doi.org/10.5578/tt.3414spa
dc.relation.referencesWurst KE, St Laurent S, Mullerova H, Davis KJ. Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study. Int J COPD. 2014;9:1021-1031. https://doi.org/10.2147/COPD.S58258spa
dc.relation.referencesHizawa N. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Int J Chron Obstruct Pulmon Dis. 2015;10:1093-1102. https://doi.org/10.2147/COPD.S72858spa
dc.relation.referencesHorhota ST, van Noord JA, Verkleij CB, Bour LJ, Sharma A, Trunk M, et al. In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers. AAPS J. 2015;17(4):871-880. https://doi.org/10.1208/s12248-015-9751-7spa
dc.relation.referencesSundh J, Osterlund Efraimsson E, Janson C, Montgomery S, Stallberg B, Lisspers K. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22(4):393-9. https://doi.org/10.4104/pcrj.2013.00087spa
dc.relation.referencesMagnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, et al. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD. N Engl J Med. 2014;371(14):1285-1294. https://doi.org/10.1056/NEJMoa1407154spa
dc.relation.referencesMehring M, Donnachie E, Fexer J, Hofmann F, Schneider A. Disease management programs for patients with COPD in Germany: A longitudinal evaluation of routinely collected patient records. Respir Care. 2014;59(7):1123-1132. https://doi.org/10.4187/respcare.02748spa
dc.relation.referencesMerino-trujillo A. Como escribir documentos científicos (Parte 3). Artículo de revisión. Salud en Tabasco. 2011;17(1 y 2):36-40.spa
dc.relation.referencesAsociación latinoamericana de tórax. Recomendaciones para el Diagnóstico y Tratamiento de la Enfermedad Pulmonar Obstructiva Crónica (EPOC). 1.a ed. Respirar. 2011. p. 1-43spa
dc.relation.referencesMolimard M, Colthorpe P. Inhaler Devices for Chronic Obstructive Pulmonary Disease: Insights from Patients and Healthcare Practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28(3):219-228. https://doi.org/10.1089/jamp.2014.1142spa
dc.relation.referencesNorris V, Ambery C. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD. Pulm Pharmacol Ther. 2013;26(5):574-580. https://doi.org/10.1016/j.pupt.2013.03.009spa
dc.relation.referencesBraido F, Baiardini I, Sumberesi M, Blasi F, Canonica GW. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res. 2013;14(1):94. https://doi.org/10.1186/1465-9921-14-94spa
dc.relation.referencesCalzetta L, Rogliani P, Matera MG, Cazzola M. A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable chronic obstructive pulmonary disease. Chest. 2016;149 (5):1181-1196. https://doi.org/10.1016/j.chest.2016.02.646.spa
dc.relation.referencesMiravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable. Aten Primaria. 2012;44(7):425-37. https://doi.org/10.1016/j.aprim.2012.04.005spa
dc.relation.referencesTashkin DP, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res. 2013;14(1):49. https://doi.org/10.1186/1465-9921-14-49spa
dc.relation.referencesLindenauer PK, Shieh M-S, Pekow PS, Stefan MS. Use and Outcomes Associated with Long-acting Bronchodilators among Patients Hospitalized for Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2014;11(8):1186-1194. https://doi.org/10.1513/AnnalsATS.201407-311OCspa
dc.relation.referencesCazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and Therapeutics of Bronchodilators. Pharmacol Rev. 2012;64(3):450-504. https://doi.org/10.1124/pr.111.004580spa
dc.relation.referencesTashkin DP, Li N, Kleerup EC, Halpin D, Celli B, Decramer M, et al. Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD. Respir Res. 2014;15(1):102. https://doi.org/10.1186/s12931-014-0102-5spa
dc.relation.referencesMagnussen H, Paggiaro P, Schmidt H, Kesten S, Metzdorf N, Maltais F. Effect of combination treatment on lung volumes and exercise endurance time in COPD. Respir Med. 2012;106(10):1413-1420. https://doi.org/10.1016/j.rmed.2012.05.011spa
dc.relation.referencesMenezes A, Macedo S. Pharmacological treatment of COPD. J Bras Pneumol. 2011;37(4):527-43. http://dx.doi.org/10.1590/S1806-37132011000400016spa
dc.relation.referencesHarries TH, Seed PT, Jones S, Schofield P, White P. Chronic obstructive pulmonary disease hospital admissions and drugs--unexpected positive associations: a retrospective general practice cohort study. NPJ Prim Care Respir Med. 2014;24:14006. https://doi.org/10.1038/npjpcrm.2014.6spa
dc.relation.referencesD´Urzo A, Donohue JF, Kardos P, Miravitlles M. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2015;16(12):1845-1860. https://doi.org/10.1517/14656566.2015.1067682spa
dc.relation.referencesOba Y, Lone NA. Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a bayesian network meta-analysis. Int J COPD. 2014;9:469-479. https://doi.org/10.2147/COPD.S48492spa
dc.relation.referencesDíaz G, Palmeiro G, Valiño M, Robles A et al. Adecuación del tratamiento inhalado en pacientes diagnosticados de enfermedad pulmonar obstructiva crónica. 2013;6(1):4-9. http://dx.doi.org/10.4321/S1699-695X2013000100002spa
dc.relation.referencesFerreira J, Drummond M, Pires N, Reis G, Alves C, Robalo-Cordeiro C. Optimal treatment sequence in COPD: Can a consensus be found? Rev Port Pneumol. 2016;22(1):39-49. https://doi.org/10.1016/j.rppnen.2015.10.009spa
dc.relation.referencesBrill SE, Wedzicha J a. Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9(1):1241-1252. https://doi.org/10.2147/COPD.S41476spa
dc.relation.referencesNishi SPE, Zhang W, Kuo Y-F, Sharma G. Oxygen therapy use in older adults with chronic obstructive pulmonary disease. PloS One. 2015;10(3):e0120684. https://doi.org/10.1371/journal.pone.0120684spa
dc.relation.referencesLou Peian, Chen Peipei, Zhang Pan, Yu Jiaxi, Wang Young, Chen Na, Zhang Li, Wu Hongmin ZJ. Efficiency and Safety of Pulmonary Rehabilitation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Respir Care. 2015;60:102-12. https://doi.org/10.12659/MSM.892769spa
dc.relation.referencesArancibia Francisco PJ. Consenso chileno de rehabilitación respiratoria en el paciente con EPOC. Rev Chil Enf Respir. 2011;27:77-79. http://dx.doi.org/10.4067/S0717-73482011000200001spa
dc.relation.referencesCameron-Tucker HL, Wood-Baker R, Owen C, Joseph L, Walters EH. Chronic disease self-management and exercise in COPD as pulmonary rehabilitation: a randomized controlled trial. Int J Chron Obstruct Pulmon Dis. 2014;9:513-23. https://doi.org/10.2147/COPD.S58478spa
dc.relation.referencesRicci C, Terzoni S, Gaeta M, Sorgente A, Destrebecq A, Gigliotti F. Physical Training and Noninvasive Ventilation in COPD Patients: A Meta-Analysis. Respir Care. 2013;59(5):709-17. https://doi.org/10.4187/respcare.02626spa
dc.relation.referencesMiyamoto N, Senjyu H, Tanaka T, Asai M, Yanagita Y, Yano Y, et al. Pulmonary rehabilitation improves exercise capacity and dyspnea in air pollution-related respiratory disease. Tohoku J Exp Med. 2014;232(1):1-8. https://doi.org/10.1620/tjem.232.1spa
dc.relation.referencesMaltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaŕe R, et al. An official American thoracic society/european respiratory society statement: Update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):15-62. https://doi.org/10.1164/rccm.201402-0373STspa
dc.relation.referencesMcNamara RJ, McKeough ZJ, McKenzie DK, Alison JA. Water-based exercise in COPD with physical comorbidities: A randomised controlled trial. Eur Respir J. 2013;41(6):1284-1291. https://doi.org/10.1183/09031936.00034312spa
dc.relation.referencesIepsen UW, Jørgensen KJ, Ringbæk T, Hansen H, Skrubbeltrang C, Lange P. A combination of resistance and endurance training increases leg muscle strength in COPD: An evidence-based recommendation based on systematic review with meta-analyses. Chron Respir Dis. 2015;12(2):132-145. https://doi.org/10.1177/1479972315575318spa
dc.relation.referencesDonaire-González D, Gimeno-Santos E, Balcells E, Rodríguez DA, Farrero E, De Batlle J, et al. Physical activity in COPD patients: Patterns and bouts. Eur Respir J. 2013;42(4):993-1002. https://doi.org/10.1183/09031936.00101512spa
dc.relation.referencesMcNamara RJ, McKeough ZJ, McKenzie DK, Alison JA. Obesity in COPD: The effect of water-based exercise. Eur Respir J. 2013;42(6):1737-9. https://doi.org/10.1183/09031936.00103613spa
dc.relation.referencesCecere L, Littman A. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. Natl Inst Health Public Access. 2011;8(4):275-84. https://doi.org/10.3109/15412555.2011.586660spa
dc.relation.referencesOrganizacion Mundial de la Salud. Enfermedad pulmonar obstructiva crónica (EPOC) [Internet]. 315. 2015. p. 1. Disponible en: http://www.who.int/mediacentre/factsheets/fs315/es/spa
dc.relation.referencesWarnier MJ, van Riet EES, Rutten FH, De Bruin ML, Sachs APE. Smoking cessation strategies in patients with COPD. Eur Respir J. 2013;41(3):727-34. https://doi.org/10.1183/09031936.00014012spa
dc.relation.referencesAbu Hassan H, Abd Aziz N, Hassan Y, Hassan F. Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients? Int J Chron Obstruct Pulmon Dis. 2014;9:493-8. https://doi.org/10.2147/COPD.S56637spa
dc.relation.referencesVerma A, Harrison A, Torun P, Vestbo J, Edwards R, Thornton J. Are pharmacists reducing COPD’S impact through smoking cessation and assessing inhaled steroid use? Respir Med. 2012;106(2):230-4. https://doi.org/10.1016/j.rmed.2011.08.011spa
dc.relation.referencesStead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012;10(12):CD008286. https://doi.org/10.1002/14651858.CD008286.pub2spa
dc.relation.referencesLopez M, Mongilardi N CW. Enfermedad pulmonar obstructiva crónica por exposicion a humo de biomasa. Rev Peru Med Exp Salud Publica. 2014;31:94-9.spa
dc.relation.referencesLee H, Kim J, Tagmazyan K. Treatment of stable chronic obstructive pulmonary disease: The GOLD guidelines. Am Fam Physician. 2013;88(10):655-63.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.spa
dc.title.translatedPharmacologic and non-pharmacologic treatment of chronic obstructive pulmonary diseaseeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREVspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

FicherosTamañoFormatoVer
Revista Investig. Salud Univ. Boyacá-345.pdf262.8Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Revista Investigación en Salud Universidad de Boyacá - 2018
Excepto si se señala otra cosa, la licencia del ítem se describe como Revista Investigación en Salud Universidad de Boyacá - 2018